Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Koves, Timothy R ^a,c,d   Noland, Robert C ^a   Bates, Andrew L ^b   Henes, Sarah T ^b   Muoio, Deborah M ^c,d,e   Cortright, Ronald N ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CPT 1; Endurance exercise training; Fiber type; Mitochondrial subpopulations; Rat

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1BETA; CITRATE SYNTHASE; FATTY ACID; ISOENZYME; MALONYL COENZYME A; PALMITIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDURANCE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME KINETICS; ENZYME REGULATION; FAST MUSCLE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GASTROCNEMIUS MUSCLE; HILL COEFFICIENT; IC 50; INTERMYOFIBRILLAR MITOCHONDRION; MALE; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SLOW MUSCLE; SUBSARCOLEMMAL MITOCHONDRION; TRAINING; TREADMILL EXERCISE;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CITRATE (SI)-SYNTHASE; ENZYME ACTIVATION; EXERTION; MALE; MALONYL COENZYME A; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; MYOFIBRILS; OXIDATION-REDUCTION; PALMITATES; PHYSICAL ENDURANCE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 17644394969     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00391.2004     Document Type: Article

References (52)

1. Abu-Elheiga L, Oh W, Kordari P, and Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 100: 10207-10212, 2003.
2. Baldwin KM, Klinkerfuss GH, Terjung RL, Mole PA, and Holloszy JO. Respiratory capacity of white, red, and intermiediate muscle: adaptive response to exercise. Am J Physiol 222: 373-378, 1972.
3. Bavenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, and Efendic S. Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. J Clin Endocrinol Metab 88: 82-87, 2003.
4. Bezaire V, Heigenhauser GJ, and Spriet LL. Regulation of CPTI activity in intermyofibrillar and subsarcolemmal mitochondria isolated from human and rat skeletal muscle. Am J Physiol Endocrinol Metab 286: E85-E91, 2004.
5. Bizeau ME, Willis WT, and Hazel JR. Differential responses to endurance training in subsarcolemmal and intermyofibrillar mitochondria. J Appl Physiol 85: 1279-1284, 1998.
6. Brooks GA, Brown MA, Butz CE, Sicurello JP, and Dubouchaud H. Cardiac and skeletal muscle mitochondria have a monocarboxylate transporter MCT1. J Appl Physiol 87: 1713-1718, 1999.
7. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, and Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36235-36241, 2004.
8. Cogswell AM, Stevens RJ, and Hood DA. Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol Cell Physiol 264: C383-C389, 1993.
9. Constable SH, Favier RJ, McLane JA, Fell RD, Chen M, and Holloszy JO. Energy metabolism in contracting rat skeletal muscle: adaptation to exercise training. Am J Physiol Cell Physiol 253: C316-C322, 1987.
10. i values. J Biol Chem 259: 12030-12033, 1984.
11. Cook GA, Mynatt RL, and Kashfi K. Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. J Biol Chem 269: 8803-8807, 1994.
12. Delp MD and Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 80: 261-270, 1996.
13. Emerit J, Edeas M, and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58: 39-46, 2004.
14. Gollnick PD and King DW. Effect of exercise and training on mitochondria of rat skeletal muscle. Am J Physiol 216: 1502-1509, 1969.
15. Guzman M and Castro J. Effects of endurance exercise on carnitine palmitoyltransferase 1 from rat heart, skeletal muscle and liver mitochondria. Biochim Biophys Acta 963: 562-565, 1988.
16. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, and Dohm GL. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol Endocrinol Metab 268: E453-E457, 1995.
17. Hollander J, Fiebig R, Gore M, Bejma J, Ookawara T, Ohno H, and Ji LL. Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training. Am J Physiol Regul Integr Comp Physiol 277: R856-R862, 1999.
18. Holloszy JO. Biochemical adaptations in muscle: effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242: 2278-2282, 1967.
19. Holloszy JO, Oscai LB, Don IJ, and Mole PA. Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise. Biochem Biophys Res Commun 40: 1368-1373, 1970.
20. Hoppeler H, Luthi P, Claassen H, Weibel ER, and Howald H. The ultrastructure of the normal human skeletal muscle. A morphometric analysis on untrained men, women and well-trained orienteers. Pflügers Arch 344: 217-232, 1973.
21. Howald H, Hoppeler H, Claassen H, Mathieu O, and Straub R. Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans. Pflügers Arch 403: 369-376, 1985.
22. Hutber CA, Rasmussen BB, and Winder WW. Endurance training attenuates the decrease in skeletal muscle malonyl-CoA with exercise. J Appl Physiol 93: 1917-1922, 1997.
23. Jimenez M, Yvon C, Lehr L, Leger B, Keller P, Russell A, Kuhne F, Flandin P, Giacobino JP, and Muzzin P. Expression of uncoupling protein-3 in subsarcolemmal and intermyofibrillar mitochondria of various mouse muscle types and its modulation by fasting. Eur J Biochem 269: 2878-2884, 2002.
24. Kashfi K and Cook GA. Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors. Biochem J 282: 909-914, 1992.
25. Kayar SR, Hoppeler H, Mermod L, and Weibel ER. Mitochondrial size and shape in equine skeletal muscle: a three-dimensional reconstruction study. Anat Rec 222: 333-339, 1988.
26. Kelley DE, He J, Menshikova EV, and Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950, 2002.
27. Kerner J, Distler AM, Minkler P, Parland W, Peterman SM, and Hoppel CL. Phosphorylation of rat liver mitochondrial carnitine palmitoyltransferase-I: effect on the kinetic properties of the enzyme. J Biol Chem 279: 41104-41113, 2004.
28. Kim JY, Hickner RC, Cortright RL, Dohm GL, and Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000.
29. Kim JY, Koves TR, Yu GS, Gulick T, Cortright RN, Dohm GL, and Muoio DM. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Am J Physiol Endocrinol Metab 282: E1014-E1022, 2002.
30. Kirkwood SP, Munn EA, and Brooks GA. Mitochondrial reticulum in limb skeletal muscle. Am J Physiol Cell Physiol 251: C395-C402, 1986.
31. Krieger DA, Tate CA, McMillin-Wood J, and Booth FW. Populations of rat skeletal muscle mitochondria after exercise and immobilization. J Appl Physiol 48: 23-28, 1980.
32. Kriketos AD, Pan DA, Sutton JR, Hoh JF, Baur LA, Cooney GJ, Jenkins AB, and Storlien LH. Relationships between muscle membrane lipids, fiber type, and enzyme activities in sedentary and exercised rats. Am J Physiol Regul Integr Comp Physiol 269: R1154-R1162, 1995.
33. Manneschi L and Federico A. Polarographic analyses of subsarcolemmal and intermyofibrillar mitochondria from rat skeletal and cardiac muscle. J Neural Sci 128: 151-156, 1995.
34. Martin TP. Predictable adaptations by skeletal muscle mitochondria to different exercise training workloads. Comp Biochem Physiol B 88: 273-276, 1987.
35. McArdle F, Spiers S, Aldemir H, Vasilaki A, Beaver A, Iwanejko L, McArdle A, and Jackson MJ. Preconditioning of skeletal muscle against contraction-induced damage: the role of adaptations to oxidants. J Physiol 561: 233-244, 2004.
36. McGarry JD, Leatherman GF, and Foster DW. Carnitine palmitoyltransferase I: the site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem 253: 4128-4136, 1978.
37. McGarry JD, Mills SE, Long CS, and Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28, 1983.
38. Mills SE, Foster DW, and McGarry JD. Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Biochem J 214: 83-91, 1983.
39. Mole PA and Holloszy JO. Exercise-induced increase in the capacity of skeletal muscle to oxidize palmitate. Proc Soc Exp Biol Med 134: 789-792, 1970.
40. Mole PA, Oscai LB, and Holloszy JO. Adaptation of muscle to exercise. Increase in levels of palmityl CoA synthetase, carnitine palmityltransferase, and palmityl CoA dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 50: 2323-2330, 1971.
41. Nemeth P and Pette D. Succinate dehydrogenase activity in fibres classified by myosin ATPase in three hind limb muscles of rat. J Physiol 320: 73-80, 1981.
42. Palmer JW, Tandler B, and Hoppel CL. Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: effects of procedural manipulations. Arch Biochem Biophys 236: 691-702, 1985.
43. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, and Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142, 2003.
44. Ruderman NB, Saha AK, Vavvas D, Heydrick SJ, and Kurowski TG. Lipid abnormalities in muscle of insulin-resistant rodents. The malonyl CoA hypothesis. Ann NY Acad Sci 827: 221-230, 1997.
45. Russell AP, Gastaldi G, Bobbioni-Harsch E, Arboit P, Gobelet C, Deriaz O, Golay A, Witztum JL, and Giacobino JP. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett 551: 104-106, 2003.
46. Ryder JW, Bassel-Duby R, Olson EN, and Zierath JR. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem 278: 44298-44304, 2003.
47. Saha AK, Kurowski TG, Colca JR, and Ruderman NB. Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am J Physiol Endocrinol Metab 267: E95-E101, 1994.
48. Schrauwen P and Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53: 1412-1417, 2004.
49. Srere PA. Citrate synthase. In: Methods in Enzymology, edited by Lowenstein JM. New York: Academic, 1969, p. 3-5.
50. Starritt EC, Howlett RA, Heigenhauser JF, and Spriet LL. Sensitivity of CPT-I to malonyl-CoA in trained and untrained human skeletal muscle. Am J Physiol Endocrinol Metab 278: E462-E468, 2000.
51. Veerkamp JH and van Moerkerk HTB. The effect of malonyl-CoA on fatty acid oxidation in rat muscle and liver mitochondria. Biochim Biophys Acta 710: 252-255, 1982.
52. Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, and Williams RS. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296: 349-352, 2002.